These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18217197)

  • 61. Post-marketing observational study on 5% intravenous immunoglobulin therapy in patients with secondary immunodeficiency and recurrent serious bacterial infections.
    Günther G; Dreger B
    Microbiol Immunol; 2013 Jul; 57(7):527-35. PubMed ID: 23607863
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders.
    Gürcan HM; Ahmed AR
    Ann Pharmacother; 2007 May; 41(5):812-23. PubMed ID: 17440006
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pneumococcal antibody levels in children with PID receiving immunoglobulin.
    Tuerlinckx D; Florkin B; Ferster A; De Schutter I; Chantrain C; Haerynck F; Philippet P; Strengers P; Laub R
    Pediatrics; 2014 Jan; 133(1):e154-62. PubMed ID: 24366995
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A smooth transition protocol for patients with multifocal motor neuropathy going from intravenous to subcutaneous immunoglobulin therapy: an open-label proof-of-concept study.
    Misbah SA; Baumann A; Fazio R; Dacci P; Schmidt DS; Burton J; Sturzenegger M
    J Peripher Nerv Syst; 2011 Jun; 16(2):92-7. PubMed ID: 21692906
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Intravenous immunoglobulin in recurrent-relapsing inflammatory optic neuropathy.
    Stiebel-Kalish H; Hammel N; van Everdingen J; Huna-Baron R; Lee AG
    Can J Ophthalmol; 2010 Feb; 45(1):71-5. PubMed ID: 20130715
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Favorable outcome of juvenile dermatomyositis treated without systemic corticosteroids.
    Levy DM; Bingham CA; Kahn PJ; Eichenfield AH; Imundo LF
    J Pediatr; 2010 Feb; 156(2):302-7. PubMed ID: 19846111
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Severe dysphagia and erythrodermia in a 59-year-old man].
    Zuber MA; Kouba M; Rudolph SE; Weller M; Hrdlicka P
    Internist (Berl); 2013 Mar; 54(3):359-65. PubMed ID: 23404266
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A Review of the Use of Intravenous Immunoglobulin Therapy in Dermatology.
    Engel C; Holcomb ZE
    Skin Therapy Lett; 2024 May; 29(3):1-4. PubMed ID: 38781951
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Therapy with immunoglobulin in patients with acute myocarditis and cardiomyopathy: analysis of leukocyte balance.
    Kishimoto C; Shioji K; Hashimoto T; Nonogi H; Lee JD; Kato S; Hiramitsu S; Morimoto SI
    Heart Vessels; 2014 May; 29(3):336-42. PubMed ID: 23702697
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Successful therapy with intravenous immunoglobulin in the management of polymyositis.
    Kristofova B; Oetterova M; Valocikova I; Macejova Z; Pidanicova A; Firment J; Majernik M; Lazurova I
    Bratisl Lek Listy; 2008; 109(9):412-3. PubMed ID: 19040148
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Intravenous immunoglobulins for refractory status epilepticus, part I: A scoping systematic review of the adult literature.
    Zeiler FA; Matuszczak M; Teitelbaum J; Kazina CJ; Gillman LM
    Seizure; 2017 Feb; 45():172-180. PubMed ID: 28068584
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Intravenous immunoglobulin in juvenile dermatomyositis--four year review of nine cases.
    Sansome A; Dubowitz V
    Arch Dis Child; 1995 Jan; 72(1):25-8. PubMed ID: 7717731
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A case of dermatomyositis with rhabdomyolysis, rescued by intravenous immunoglobulin.
    Mizoguchi F; Takada K; Ishikawa K; Mizusawa H; Kohsaka H; Miyasaka N
    Mod Rheumatol; 2015 Jul; 25(4):646-8. PubMed ID: 24252047
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Intravenous Immunoglobulin Therapy in Livedoid Vasculopathy: Retrospective Observation of Clinical Outcome and Patient's Activity Level.
    Kofler K; Strölin A; Geiger V; Kofler L
    J Cutan Med Surg; 2021 Sep; 25(5):504-510. PubMed ID: 33779349
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Eczematous reaction to IVIG for the treatment of dermatomyositis.
    Berk-Krauss J; Lee K; Lo Sicco KI; Liebman TN
    Int J Womens Dermatol; 2018 Sep; 4(3):170-173. PubMed ID: 30175220
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Paraneoplastic dermatomyositis: efficacy of intravenous gammaglobulin.
    Esteve E; Cambie MP; Serpier H; Vanderbroere-Bouquet A; Bellaiche P; Kalis B
    Br J Dermatol; 1994 Dec; 131(6):917-8. PubMed ID: 7857856
    [No Abstract]   [Full Text] [Related]  

  • 77. Teaching Video NeuroImage: Response to IVIg in a Patient With Steroid-Refractory Immune Checkpoint Inhibitor-Related Ocular Myopathy.
    Hooshmand SJ; Aragon Pinto C; Liewluck T; Pinto MV
    Neurology; 2023 Nov; 101(21):e2204. PubMed ID: 37788932
    [No Abstract]   [Full Text] [Related]  

  • 78. Role of intravenous immunoglobulin in severe steroid-dependent asthma.
    Haque S; Boyce N; Thien FC; O'Hehir RE; Douglass J
    Intern Med J; 2003 Aug; 33(8):341-4. PubMed ID: 12895163
    [TBL] [Abstract][Full Text] [Related]  

  • 79. High-dose immunoglobulin therapy for a patient with dermatomyositis.
    Furuya Y; Takahashi T; Hamamoto H; Nishimura M; Kawakami Y
    Intern Med; 1998 Jul; 37(7):642-5. PubMed ID: 9711898
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Successful multimodality treatment of recalcitrant necrobiotic xanthogranuloma using electron beam radiation and intravenous immunoglobulin.
    Nambudiri VE; McLaughlin C; Lo TC; Zembowicz A; Moschella S
    Clin Exp Dermatol; 2016 Mar; 41(2):179-82. PubMed ID: 26206141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.